Testing has been at the heart of the national strategy to tackle Covid-19. But after 2 months do any of us fully understand the real issues around testing? While so many questions at the Downing Street press conferences have focussed on targets and numbers of tests, scientists heavily involved in testing have been more worried about the quality of testing and standardising tests globally with a view to gathering the most useful information to tackle the pandemic. Given that science and health journalists will continue to be reporting on different aspects of testing and indeed multiple kinds of tests, we thought we would offer this Q&A with leading experts who we hoped could answer any remaining questions/confusions.
Journalists attended our expert panel to learn:
Prof David Heymann, Professor of Infectious Disease Epidemiology at the London School of Hygiene & Tropical Medicine (LSHTM)
Dr Catharina Boehme, Chief Executive Officer of FIND (Foundation for Innovative New Diagnostics)
Dr Jim Huggett, Principal Scientist in LGC’s Health Science and Innovation Division and Senior Lecturer in Analytical Microbiology at the University of Surrey